Stocks and Investing
Stocks and Investing
Tue, May 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 4, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (AGIO) at Buy with Increased Target to $82 on, May 4th, 2020
Anupam Rama of JP Morgan, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $72 to $82 on, May 4th, 2020.
Anupam has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Peter Lawson of "Barclays" Initiated at Hold and Held Target at $50 on, Wednesday, March 4th, 2020
This is the rating of the analyst that currently disagrees with Anupam
- Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $70 on, Friday, February 14th, 2020